Rudin Christoph

Prof. Dr. Rudin Christoph

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MBMichael Buettcher
Michael Buettcher
JTJohannes Trueck
Johannes Trueck
ANAnita Niederer-Loher
Anita Niederer-Loher
UHUlrich Heininger
Ulrich Heininger
PAPhilipp Kwame Abayie Agyeman
Philipp Kwame Abayie Agyeman
TNThomas J. Neuhaus
Thomas J. Neuhaus
The kidneys and the urinary tract are a common source of infection in children of all ages, especially infants and young children. The main risk factors for sequelae after urinary tract infections (UTI) are congenital anomalies of the kidney and urinary tract (CAKUT) and bladder-bowel dysfunction. UTI should be considered in every child with fever without a source. The differentiation between upper and lower UTI is crucial for appropriate management. Method of urine collection should be based on age and risk factors. The diagnosis of UTI requires urine analysis and significant growth of a pathogen in culture. Treatment of UTI should be based on practical considerations regarding age and presentation with adjustment of the initial antimicrobial treatment according to antimicrobial sensitivity testing. All children, regardless of age, should have an ultrasound of the urinary tract performed after pyelonephritis. In general, antibiotic prophylaxis is not recommended.Conclusion: Based on recent data and in line with international guidelines, multidisciplinary Swiss consensus recommendations were developed by members of Swiss pediatric infectious diseases, nephrology, and urology societies giving the clinician clear recommendations in regard to diagnosis, type and duration of therapy, antimicrobial treatment options, indication for imaging, and antibiotic prophylaxis. What is Known:•Urinary tract infections (UTI) are a common and important clinical problem in childhood. Although children with pyelonephritis tend to present with fever, it can be difficult on clinical grounds to distinguish cystitis from pyelonephritis, particularly in young children less than 2 years of age.•Method of urine collection is based on age and risk factors. The diagnosis of UTI requires urine analysis and significant growth of a pathogen in culture. What is New:•Vesicoureteric reflux (VUR) remains a risk factor for UTI butper seis neither necessary nor sufficient for the development of renal scars. Congenital anomalies of the kidney and urinary tract (CAKUT) and bladder-bowel dysfunction play a more important role as causes of long-term sequelae. In general, antibiotic prophylaxis is not recommended.•A switch to oral antibiotics should be considered already in young infants. Indications for invasive imaging are more restrictive and reserved for patients with abnormal renal ultrasound, complicated UTI, and infections with pathogens other than E. coli.

18 August 2010 in HIV Medicine
Verified
Journal Article
Closed access
PDF file
RCRudin Christoph
Rudin Christoph
ASA Spaenhauer
A Spaenhauer
OKO Keiser
O Keiser
MRM Rickenbach
M Rickenbach
CKC Kind
C Kind
T(the Swiss HIV Cohort Study (SHCS) & the Swiss Mother & Child HIV Cohort Study (MoCHiV)
the Swiss HIV Cohort Study (SHCS) & the Swiss Mother & Child HIV Cohort Study (MoCHiV)

15 October 2009 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
T(The Swiss Pediatric Surveillance Unit (Spsu)
The Swiss Pediatric Surveillance Unit (Spsu)
ASAlexandra Schifferli
Alexandra Schifferli
RVRodo O. von Vigier
Rodo O. von Vigier
MFMatteo Fontana
Matteo Fontana
GSGiuseppina Spartà
Giuseppina Spartà
RCRudin Christoph
Rudin Christoph

1 September 2013 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
KAKaroline Aebi-Popp
Karoline Aebi-Popp
FMFiona Mulcahy
Fiona Mulcahy
TGTracy R. Glass
Tracy R. Glass
RCRudin Christoph
Rudin Christoph
BTBegona Martinez de Tejada
Begona Martinez de Tejada
CTClaire Thorne
Claire Thorne
Most national guidelines for the prevention of mother-to-child transmission of HIV in Europe updated between 2001 and 2010 recommend vaginal deliveries for women with undetectable or very low viral load (VL). Our aim was to explore the impact of these new guidelines on the rates of vaginal deliveries among HIV-positive women in Europe

18 October 2014 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MBMarie-Anne Burckhardt
Marie-Anne Burckhardt
ASAlexandra Schifferli
Alexandra Schifferli
AKAndreas H. Krieg
Andreas H. Krieg
DBDaniel Baumhoer
Daniel Baumhoer
GSGabor Szinnai
Gabor Szinnai
RCRudin Christoph
Rudin Christoph

1 November 2018 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
RCRudin Christoph
Rudin Christoph
HHHans H. Hirsch
Hans H. Hirsch
RSRahel Spaelti
Rahel Spaelti
SSSabine Msc Schaedelin
Sabine Msc Schaedelin
Thomas KlimkaitThomas Klimkait
Thomas Klimkait
Background: Due to the lack of prospective data, there is an ongoing debate about the need for screening and prevention programs for congenital toxoplasmosis in Europe. Accordingly, individual countries have chosen different public health strategies. Methods: A cord-blood screening program for congenital toxoplasmosis was established in 1982 in obstetric units of hospitals in North-Western Switzerland. Samples were tested for specific immunoglobulin G (IgG) and IgM, and after 1992 also for IgA antibodies. Suspicious test results triggered additional investigations to identify children with congenital toxoplasmosis. Results: From 1982 to 2015, 119,166 cord-blood samples have been collected and analyzed for the presence of Toxoplasma-specific antibodies. Although maternal age rose from 28.2 to 32.2 years during this period, a decrease of seroprevalence from 53% to 20% was observed. The incidence of congenital toxoplasmosis decreased by 85% (from 0.08% to 0.012%) and remained low despite abandoning prevalent nonsystematic screening during pregnancy in Switzerland. Conclusions: Our data document a steady decline of both Toxoplasma gondii seroprevalence and congenital toxoplasmosis incidence in Switzerland even after abolition of the nonsystematic prenatal screening a decade ago. The data support abandoning toxoplasmosis screening programs in low-incidence, high-income countries such as Switzerland.